Pro-HPV Vaccine Doc Omits Financial Ties in Medical Journal

One of the biggest promoted drugs in history, the HPV cervical cancer vaccine, is a multi-billion dollar blockbuster. But it’s also faced criticism — some of it from a scientist who helped develop it —  amid concerns about safety and effectiveness

When Japan suspended proactively recommending the vaccine amid concerns over injuries, the makers, Merck (Gardasil) and GlaxoSmithKline (Cevarix), began the hard lobby.

Enter a physician who wrote a correspondence about the controversy in this week’s online version of The Lancet medical journal. Dr. Sharon J.B. Hanley defended the HPV vaccine and dismissed reports of side effects blaming the “media” environment for all the fuss. There’s just one key fact that she left out…

Read the article here:

More HPV vaccine stories and CDC government resources here:

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top